Is this your brand? Sign in to claim ownership.
Sign in to claim this brandWhat REVVITY DISCOVERY LIMITED makes
Revvity Discovery Limited manufactures in vitro diagnostic (IVD) reference standards and controls for cancer-related genetic testing, including multiplex gene mutation profiling. Their products are designed for use with formalin-fixed paraffin-embedded (FFPE) tissue samples and genomic DNA (gDNA), covering myeloid cancer panels and quantitative multiplex assays.
These devices are classified as Class I under regulatory frameworks and are listed in the FDA’s Unique Device Identifier (UDI) database. The company operates from the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 345534338
Catalogue (4)
| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Mimix™ OncoSpan FFPE Reference Standard | HD832-IVD | FDA UDI | Class I | Active |
| Mimix™ OncoSpan gDNA Reference Standard | HD827-IVD | FDA UDI | Class I | Active |
| Mimix™ Quantitative Multiplex FFPE reference standard | HD200-IVD | FDA UDI | Class I | Active |
| Mimix™ Myeloid Cancer Panel gDNA Reference Standard | HD829-IVD | FDA UDI | Class I | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.